COMPARISION THE CLINICAL, PARACLINICAL AND TREATMENT BETWEEN PROSTHETIC VALVE ENDOCARDITIS AND NATIVE VALVE ENDOCARDITIS
Main Article Content
Abstract
Objective: Retrospective study of 84 patients treated at the Cardiovascular Center of E Hospital to compare clinical, paraclinical and treatment between prostheticvalve endocarditis (PVE) and native valve endocarditis (NVE). Results: The proportion of PVE was 27.4%. NVE group showed significantly higher rate of prolonged fever and systolic murmur than PVE group. Vegetation was commonly found in the aortic valve in PVE group, on the contrary commonly found in the mitral valve in NVE group. The rate of periannular abscess in PVE group was significantly higher than in NVE group. In PVE group, the rate of antibiotic change was significantly higher and the duration of antibiotic use was longer than in NVE group. The rate of good progression was not different between two groups. Conclusion: Because PVE group showed notably high rate of periannular abscess, high rate of antibiotic change and longer duration of treatment, more studies with large numbers are needed to carried out to propose the suitable antibiotic for empiric therapy and effective treatment duration for PVE.
Article Details
Keywords
Endocarditis, prostheticvalve endocarditis, native valve endocarditis
References
2. Fernández-Hidalgo N, Almirante B, Tornos P, et al. Contemporary epidemiology and prognosis of health care-associated infective endocarditis. Clin Infect Dis Off Publ Infect Dis Soc Am. 2008;47(10):1287-1297. doi:10.1086/ 592576
3. Khalil H, Soufi S. Prosthetic Valve Endocarditis. In: StatPearls. StatPearls Publishing; 2023. Accessed June 3, 2023. http://www.ncbi. nlm.nih.gov/books/NBK567731/
4. Tornos P, Iung B, Permanyer-Miralda G, Baron G, Delahaye F, Gohlke- Barwolf C, et al. Infective endocarditis in Europe: lessons from the Euro heart survey. Heart. 2005;91:571-5.
5. Romano G.,Carozza A., Della Corte A. et al. Native versus primary prosthetic valve endocarditis: comparison of clinical features and long-term outcome in 353 patients. J Heart Valve Dis. 2004;13:200-9.
6. Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015; 36(44): 3075-3128. doi:10.1093/eurheartj/ ehv319
7. Habib G, Erba PA, Iung B, et al. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J. 2019; 40(39): 3222-3232. doi:10.1093/eurheartj/ ehz620.
8. Nguyễn Thị Thu Hoài, Phạm Minh Tuần, Trần Bá Hiếu. Viêm nội tâm mạc nhiễm khuẩn tại Bệnh viện Bạch Mai, 2012 - 2017. Tạp chí Tim mạch học Việt Nam. 2019;(87):48-54.
9. Hoang M Tran, Vien T Truong, Tam MN Ngo, et al. Microbiological profile and risk factors for in-hospital mortality of infective endocarditis in tertiary care hospitals of south Vietnam. PLoS One. 2017;12(12):e0189421. doi:10.1371/journal. pone. 0189421.
10. Pyo WK, Kim HJ, Kim JB, et al. Comparative Surgical Outcomes of Prosthetic and Native Valve Endocarditis. Korean Circ J. 2021;51(6):504-514. doi:10.4070/kcj.2020.0448